Clinical trial
Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC
NCT03742687
Study timeline
Study start (actual)2018-11-22Date precision: day
Registry last updated2023-09-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Stage III Non-small-cell Lung Cancerunresolved
Stage IV Non-small Cell Lung Cancerunresolved
Radiotherapy Side Effectunresolved
Interventions
Sponsors & collaborators
Danish Lung Cancer Grouplead sponsor
Odense University Hospitalcollaborator
Copenhagen University Hospital, Rigshospitaletcollaborator
Vejle Hospitalcollaborator
Herlev Hospitalcollaborator
Aarhus University Hospitalcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03742687 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.